Although 1,25-dihydroxyvitamin D3 stimulates osteoclastic bone resorption in vivo and in organ culture, the mechanism by which it effects this stimulation is unknown. 
Introduction
1 ,25-Dihydroxyvitamin D3 (l,25(0H)2D3)' is essential for mineralization of bone and cartilage, and defective mineralization is the most notable pathological feature of deficiency of the hormone. The main mechanism through which 1,25(OH)2D3 induces bone and cartilage calcification is believed to be indirect, through an increase in the concentration of calcium and phosphate in the serum (1) (2) (3) . 1 ,25(OH)2D3 also stimulates bone resorption in vivo (4) (5) (6) be direct, because increased osteoclastic resorption is induced in organ cultures of bone in vitro (7, 8) .
The mechanism by which 1,25(OH)2D3 stimulates bone resorption is unknown. Receptors have been identified in osteoprogenitor cells and osteoblasts but not in osteoclasts (9, 10) . Either receptors are present in osteoclasts in numbers sufficient for stimulation of function but insufficient for identification, or the hormone stimulates osteoclastic resorption indirectly. Indirect stimulation may occur through interaction with other bone cells that possess receptors. Alternatively it has been suggested that precursors of osteoclasts, unlike mature cells, may possess receptors that stimulate osteoclastic precursors to differentiate into osteoclasts (10) .
We have recently developed methods whereby osteoclasts can be disaggregated from bone and sedimented and widely dispersed onto slices of devitalized cortical bone (11). The Bone resorption was assessed after 24 h incubation, when the majority of osteoclasts have formed excavations in the surface of the bone slices (12, 14), the extent ofwhich was assessed by morphometric means (15) . Cells were removed from bone slices by immersion in sodium hypochlorite for 10 min. The bone slices were then dehydrated in alcohol, sputter-coated with gold, and the entire surface ofeach slice was examined in an S90 scanning electron microscope (Cambridge Instruments, Cambridge, UK). Bone resorption was measured by transferring the outline of each osteoclastic excavation to a microcomputer through a digitizing tablet. This enabled computation of the number of pits on each bone slice and their mean plan area ofresorption, as previously described (15) .
Alkaline phosphatase histochemistry was performed on the osteoblastic populations by substitution of 6-mm glass coverslips for bone slices. After incubation for 24 h the cells were fixed in 10% formal calcium (30 s), and the presence of alkaline phosphatase was demonstrated by the naphthol AS-BI method (16 The supernatants were substituted for the cell suspensions used in the previous experiments.
Statistics. Gabriel's one-way analysis ofvariance was used throughout (17) , except for $P < 0.001. * P < 0.05 for treated to control ratio mean±SE using a one-sample t test after log transformation of the data. pH of incubation medium was measured at the end of the experiment and was 6.9±0.07 and 6.89±0.05 for test and control supernatant, respectively (mean±SE).
'P < 0.01 using Gabriel's one-way analysis of variance. The sensitivity of cocultures of osteoblastic cells and disaggregated osteoclasts was assessed using calvarial cells after incubation to confluence. Significant stimulation was observed at concentrations of 10-10 M 1,25(OH)2D3 and above (Table II) .
This compares with stimulation of resorption in organ culture observed at concentrations of 1,25(OH)2D3 of 10-9 to 10-l M (7, 8, 18) .
Stimulation ofbone resorption in the presence ofUMR cells and 1,25(QH)2D3 was abolished by cycloheximide and actinomycin D (Tables III and IV) . Neither agent significantly influenced bone resorption by osteoclasts incubated alone, and both Results expressed as mean±SE of three consecutive experiments (four bone slices per group in each experiment). OC, osteoclasts; UMROC, osteoclasts in presence of UMR cells; AD, actinomycin D. * P < 0.05 compared with all other groups (Gabriel's one-way analysis of variance).
J agents were also present in cocultures of UMR cells and osteoclasts incubated with and without the hormone (Tables III and  IV) . These results suggest that the inhibitors were acting to prevent 1,25(OH)2D3 stimulation of osteoclastic bone resorption through an effect on UMR cells rather than to directly interfere with osteoclastic function, and that UMR cells mediate 1,25(OH)2D3 stimulation of resorption through an RNA and protein synthesis-dependent mechanism. We found that supernatants from both calvarial cells and UMR cells incubated for 24 h with 1,25(OH)2D3-stimulated bone resorption by osteoclasts compared with supernatants from osteoblastic cells incubated without the hormone (but to which hormone was added before incubation with osteoclasts) (Table I). (20) , they are absent from the cell type that contributes to the major effect of increased hormonal levels. A likely explanation is that osteoclasts are derived from wandering, hematogenous cells (21), and direct stimulation of the function of these may lead to random increase in bone resorption. Instead, increased osteoclastic resorption is mediated by cells of the osteoblastic lineage, which may have access to physiochemical and morphogenetic information derived from the adjacent and subjacent cells with which they make intimate contact through profuse cytoplasmic processes. This may enable only those osteoclasts in the most appropriate sites to be stimulated to increased resorption. We have found that parathyroid hormone, like 1,25(OH)2D3, also increases osteoclastic bone resorption through a primary hormonal interaction with osteoblastic cells (14) , which it similarly induces to produce a supernatant factor that stimulates osteoclasts (22) . It is possible that the same factor mediates the stimulation caused by both hormones, and it may be that regulation ofosteoblastic production ofthe osteoclast-stimulating factor is a final common pathway through which diverse local and systemic hormonal stimuli influence osteoclastic resorption.
